Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...
PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...
Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo.
Exelixis (EXEL) on Wednesday announced that the Food and Drug Administration has approved cabozantinib, or Cabometyx, for the treatment of ...
After canceling a planned advisory committee meeting, the FDA has approved Exelixis’ Cabometyx for neuroendocrine tumors. | ...
The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.
Exelixis (EXEL) wins FDA approval for Cabometyx for advanced pancreatic and extra pancreatic neuroendocrine tumors in ...
The FDA approved cabozantinib for previously treated, unresectable, locally advanced or metastatic, well-differentiated ...
Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...
(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S ...
For many years, doctors and researchers have known the correlation between moderate to severe alcohol use with oral and throat cancers, along with liver and pancreatic cancers. New evidence now ...
Australian Skye Nicolson (left) fights at home for the first time as world champion Briton Nina Hughes called for "fair judging" in Australia while fellow challenger Tiara Brown labelled world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results